Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Two new analyses come to different conclusions about the risk for severe illness and death.
Ample information, respectful interactions with clinicians and follow-up could be keys to supporting Black women in the South to use PrEP.
The novel HIV capsid inhibitor also shows promise for previously untreated people.
Hint: It’s not HIV-care-as-usual approaches.
Study will test whether providing both together will improve HIV protection for trans women.
What this means for women’s HIV acquisition rates is unclear.
Disparities extend from HIV acquisition all the way through to hospitalization and AIDS-defining illnesses.
Awareness of the HIV prevention pills don’t match their use.
Study suggests HIV-positive women could start cervical cancer screening at age 21.
Immigrants and girls had worse HIV outcomes in this study.
White men and smokers are more likely to have arterial plaque despite low cardiovascular risk scores.
The current design of the HIV care continuum is a straight line from diagnosis to an undetectable viral load.
Injections given every month or every other month were preferred over daily pills.
The immune response to the single-shot Johnson & Johnson vaccine remained robust against variants of SARS-CoV-2.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.